Familial hypercholesterolaemia: open trials in Norway

• NCT07473843

  Study of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia

  Trial Treatment · Phase 3 · Arrowhead Pharmaceuticals

  Oslo Universitetssykehus HF, Oslo

  Registry updated 2026-10-26

• NCT07058077

  A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)

  Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC

  Oslo University Hospital HF, Oslo

  Registry updated 2026-10-07

• NCT05682378

  Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Oslo

  Registry updated 2026-09-18

• NCT07102511

  Study to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FH

  Trial Treatment · Phase 3 · LIB Therapeutics LLC

  Oslo Universitetssykehus HF, Oslo

  Registry updated 2026-07-28

• 2025-521589-83-00

  Reassessment of statin-associated muscle symptoms in adults with familial hypercholesterolemia

  Trial Treatment · Phase 4 · Oslo University Hospital HF

  Oslo Universitetssykehus HF, Oslo · St. Olavs hospital HF, Trondheim

  Registry updated 2026-05-22

All Familial hypercholesterolaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error